BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Roshanshad R, Roshanshad A, Fereidooni R, Hosseini-Bensenjan M. COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations. World J Hepatol 2023; 15(4): 441-459 [PMID: 37206656 DOI: 10.4254/wjh.v15.i4.441]
URL: https://www.wjgnet.com/1007-9327/full/v15/i4/441.htm
Number Citing Articles
1
Jorge Quarleri, M Victoria Delpino. Molecular mechanisms underlying SARS-CoV-2 hepatotropism and liver damageWorld Journal of Hepatology 2024; 16(1): 1-11 doi: 10.4254/wjh.v16.i1.1
2
Beatrice A. Golomb, Jun Hee Han, Peter H. Langsjoen, Eero Dinkeloo, Alice E. Zemljic-Harpf. Statin Use in Relation to COVID-19 and Other Respiratory Infections: Muscle and Other ConsiderationsJournal of Clinical Medicine 2023; 12(14): 4659 doi: 10.3390/jcm12144659
3
Lokjan Singh, Anil Kumar, Maya Rai, Bibek Basnet, Nishant Rai, Pukar Khanal, Kok-Song Lai, Wan-Hee Cheng, Ahmed Morad Asaad, Shamshul Ansari. Spectrum of COVID-19 induced liver injury: A review reportWorld Journal of Hepatology 2024; 16(4): 517-536 doi: 10.4254/wjh.v16.i4.517
4
B. N. Levitan, T. V. Serdyukova, V. V. Skvortsov. Liver pathology in COVID-19 after end of pandemic: Modern view of problemMedical alphabet 2024; (34): 10 doi: 10.33667/2078-5631-2023-34-10-15
5
Agata Michalak, Tomasz Lach, Karolina Szczygieł, Halina Cichoż-Lach. COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?International Journal of Molecular Sciences 2024; 25(4): 2212 doi: 10.3390/ijms25042212